SOM Biotech to participate at the BIO International Convention 2021

SOM Biotech announces its participation in the BIO International Convention 2021 on June 10th – 18th, that will take place digitally. Hosted by the Biotechnology Innovation Organisation, the event is the largest global event for the biotechnology industry that attracts the leading biotech companies, scientists, research institutions, advisors, and qualified investors, providing extensive networking and …

SOM Biotech to participate at the BIO-Equity Europe 2021

SOM Biotech announces its participation in the BIO-Equity Europe 2021 event on May 17th – 19th, which will take place digitally. Organized by Biocentury and the EBD Group, the BIO-Equity 2021 event attracts leading innovative pharma and biotech companies as well as specialized investors in life sciences. The event enables the exchange of the latest …

SOM Biotech announces a presentation of the Phase 2 clinical results of SOM3355 for the treatment of chorea in Huntington´s disease

SOM3355 for chorea in Huntington´s disease

SOM Biotech will present results from the Phase 2 clinical study of SOM3355 for the treatment of chorea symptoms in Huntington´s disease at the XXVI World Congress on Parkinson’s Disease and Related Disorders, to be held May 1st – 4th 2021. The International Association for Parkinsonism and Related Disorders (IAPRD) has accepted the abstract for …

SOM Biotech at the “AI-Driven Drug Repositioning & Repurposing” Event

AI-Driven Drug Repositioning & Repurposing

SOM Biotech will attend the “AI-Driven Drug Repositioning & Repurposing” digital congress on April 20th – 21st. Organized by Hanson Wade, the “AI-Driven Drug Repositioning & Repurposing” event aims at featuring real-life case studies and experiences from companies that prove that introducing artificial intelligence in drug repurposing and repositioning is a game-changer in the industry, …

SOM Biotech to participate at the BIO-Europe Spring

Bio-Europe Spring 2021

SOM Biotech announces its participation in the BIO-Europe Spring 2021 partnering event on March 22nd – 25th, which will take place digitally due to the pandemic situation. Organized by the EBD Group, a global partnering event organizer, the BIO-Europe Spring event attracts leading decision-makers not only from the traditional pharma and biotech sectors but also …

SOM Biotech at Chiba Healthcare Business Forum 2021

SOM Biotech ends 2020 with an advanced and robust pipeline

SOM Biotech will attend the “Chiba Global Healthcare Business Forum 2021” on February 3rd – 4th, which will take place digitally due to the pandemic situation. Organized by the Japanese External Trade Association, the Chiba Healthcare Business Forum attracts the most advanced academic and research institutions as well as healthcare and life science companies worldwide …

SOM Biotech ends 2020 with an advanced and robust pipeline that strengthens the company’s future

SOM Biotech ends a notable year 2020

SOM Biotech ends the notable year 2020 with relevant advances in its pipeline. The company started 2020 with positive results from the Phase 2a proof-of-concept to evaluate the safety and efficacy of SOM3355, an inhibitor of the Vesicular Monoamine Transporter-2 (VMAT2), in Huntington´s disease (HD) patients with chorea. The clinical efficacy of SOM3355 in reducing …

SOM Biotech at the BIO- Partnering JPM Virtual Event 2021

SOM Biotech announces its participation at the BIO-Partnering at JP Morgan Healthcare Conference 2021, being held virtually on January 11th – 15th. The conference, a leading virtual partnering and business development initiative for the biotechnology industry organized by Biotechnology Innovation Organization, provides a One-on-One partnering platform to give companies access to potential strategic partners and …